Autoimmune Phenomena and New‐Onset Type 1 Diabetes Following SARS‐CoV‐2 Vaccination: A Personal Perspective
Immunity, Inflammation and Disease · 2026-04 · 14 (4)
DOI: 10.1002/iid3.70419 ↗Kurz gefasst
Leserbrief in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 27.04.2026. Verfasst von Kimihiko Sugaya. Beteiligte Einrichtung: Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST)…. Hauptthemen laut MEDLINE: Autoimmune Diseases, COVID-19, COVID-19 Vaccines, Diabetes Mellitus, Type 1. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
A molecular biologist whose wife suddenly developed type I diabetes in the summer of 2022 addresses the possible risk of developing autoimmune disease from messenger RNA (mRNA) vaccination against SARS-CoV-2. This essay also provides a record of the tough fight against autoimmune disease continuing to the present day, the prospect for therapeutics to control type I diabetes, and the author's for standing by his wife.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.
ORCID-Profile: Kimihiko Sugaya
Zitieren
APA
Sugaya, K. (2026). Autoimmune Phenomena and New‐Onset Type 1 Diabetes Following SARS‐CoV‐2 Vaccination: A Personal Perspective. Immunity, Inflammation and Disease, 14(4). https://doi.org/10.1002/iid3.70419
Vancouver
Sugaya K. Autoimmune Phenomena and New‐Onset Type 1 Diabetes Following SARS‐CoV‐2 Vaccination: A Personal Perspective. Immunity, Inflammation and Disease. 2026;14(4). doi:10.1002/iid3.70419
BibTeX
@article{Sugaya2026,
author = {Sugaya, Kimihiko},
title = {Autoimmune Phenomena and New‐Onset Type 1 Diabetes Following SARS‐CoV‐2 Vaccination: A Personal Perspective},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/iid3.70419}
}
EUVIMED